Republican Senators Will Oppose Radically Pro-Abortion Biden FDA Nominee Robert Califf

National   |   Micaiah Bilger   |   Jan 19, 2022   |   1:04PM   |   Washington, DC

Two U.S. Senate Republicans no longer plan to support the confirmation of Robert Califf as director of the Food and Drug Administration after learning of his pro-abortion record.

Califf’s confirmation is less certain now that pro-life Republicans Tommy Tuberville, of Alabama, and Roger Marshall, of Kansas, oppose him, Politico reports.

For weeks, pro-life organizations have been urging senators to oppose Califf because he was instrumental in expanding sales of the abortion pill, which has killed dozens of women, injured thousands more and killed millions of unborn babies.

Califf has “a track record of rubber-stamping abortion industry demands,” wrote a coalition of 49 pro-life organizations, including LifeNews.com, in a letter to U.S. Senators last week.

Though Tuberville initially was unsure about Califf, he said he decided to oppose him after learning of the nominee’s pro-abortion actions, according to the report.

“Just a few days after Dr. Califf’s confirmation hearing, the FDA announced it would permanently allow abortion drugs to be available by mail order,” Tuberville told Politico in a statement. “I believe Dr. Califf will continue to advance this administration’s pro-abortion agenda, and I cannot support his nomination.”

ACTION ALERT: Contact members of the Senate to urge a no vote on Califf’s nomination.

The Biden nominee also worked as FDA director for President Barack Obama. Under Califf, the agency got rid of some of the safety regulations on the abortion drug mifepristone, allowing it to be prescribed later in pregnancy and by a non-physician. It also stopped requiring non-fatal complications to be reported to the FDA.

The Susan B. Anthony List, one of the pro-life organizations lobbying against Califf, pointed out these and other concerns in a letter to lawmakers earlier this month, National Review reports.

“Under Califf’s leadership during the Obama Administration, the FDA significantly undermined the reporting and safety requirements on medication abortion, also known as chemical abortion,” the letter said. “The FDA needs a leader who will follow the science and prioritize the health and wellbeing of women and girls. Based on his past (successful) effort to weaken data and safety requirements for chemical abortion, we must oppose his nomination.”

Califf’s chances of being confirmed are looking more dim as politicians from both parties voice objections to his past actions on various issues.

Here’s more from the report:

The stakes are high because five Senate Democrats have publicly opposed Califf over his record on opioids the last time he led FDA, late in the Obama administration, as well as his time in the corporate sector. With only four Republicans on the record supporting his confirmation and the possibility of more Democratic defections, peeling off even one or two more Republicans could prove fatal to Califf’s chances.

However, White House spokesperson Chris Meagher said the Biden administration is “confident he’ll be confirmed with bipartisan support.”

Last week, the Senate HELP Committee voted 13-8 to advance Califf’s nomination. Six Republicans — Bill Cassidy of Louisiana, Mike Braun of Indiana, Roger Marshall of Kansas, Tim Scott of South Carolina, Tommy Tuberville of Alabama and Jerry Moran of Kansas — voted against Califf along with Democrats Bernie Sanders of Vermont and Maggie Hassan of New Hampshire.

Republicans Richard Burr of North Carolina, Mitt Romney of Utah, Lisa Murkowski of Alaska and Susan Collins of Maine voted for Califf’s nomination.

It is not clear when the full U.S. Senate will vote on his confirmation.

Califf also served in the FDA role during the Obama administration. Under Califf’s leadership, the FDA weakened safety regulations for the abortion drug mifepristone, also known as RU-486 or Mifeprex.

In the United States, the FDA has linked the abortion drug to at least 24 women’s deaths and 4,000 serious complications. Notably, however, under Califf, the FDA stopped requiring that non-fatal complications from mifepristone be reported to the government. So the numbers very well could be higher.

Mifepristone is an abortion drug used to abort unborn babies up to about 10 weeks of pregnancy. It works by blocking the hormone progesterone and basically starving the unborn baby to death. Typically, women also are prescribed a second drug, misoprostol, that induces labor and expels their aborted baby’s body.

For many years, the FDA has required licensed medical professionals to provide mifepristone in-person after a medical exam – safety regulations that protect women from potentially life-threatening complications.

In December, however, the Biden administration got rid of many of these safety regulations and began allowing abortion businesses to sell the drugs through the mail without ever seeing the woman in person.

ACTION ALERT: Contact members of the Senate to urge a no vote on Califf’s nomination.